What Happens If Your FDA U.S. Agent Resigns or Lapses — Lockout Risk and How Fast to Replace

Published: · Last Updated:

When to use this playbook

  • Your U.S. Agent resigned, terminated service, went out of business, or stopped responding.
  • Your service contract expired and you do not know whether the agent still considers itself designated.
  • FDA, your importer, or your broker has questioned the U.S. Agent information on the registration.
  • A food, cosmetic, medical device, or drug shipment is approaching while the agent designation is uncertain.
  • You need to distinguish a stale contact record from a valid, accepted U.S. Agent relationship.

Your goal is to establish the effective date of the agent loss, regain control of the relevant FDA account, appoint a replacement, complete any required acceptance step, and confirm that the registration record is current before the gap reaches a shipment or FDA communication.

What success looks like

  • The new U.S. Agent is entered in the correct FDA system and has accepted the designation where confirmation is required.
  • The facility or establishment record shows a current status rather than a draft, pending, unconfirmed, or outdated submission.
  • The importer and customs broker have the correct registration and agent details before the next entry is filed.
  • Any FDA notices received during the gap have been located, triaged, and assigned.
  • The next registration renewal and agent-service renewal have separate owners and calendar controls.

Three clocks determine how urgent the replacement is

A contract lapse, an agent resignation, and removal from an FDA record are not necessarily the same event. Treat the incident as three concurrent clocks rather than waiting for one universal cancellation notice.

Clock What it measures Practical rule
Agent relationship When the prior agent stopped agreeing to serve or stopped providing coverage. Use the written resignation or termination date. A name remaining in a portal does not prove that coverage remains active.
Regulatory update The deadline for correcting required registration information. Medical device agent changes must be reported within 10 business days; drug agent information changes require an update within 30 calendar days; food and cosmetic registration changes generally carry 60-calendar-day update duties. Authorities: 21 CFR 807.40, FDA drug registration update guidance, FDA food U.S. Agent guidance, and 21 U.S.C. 364c.
Market access The next shipment, inspection request, emergency communication, renewal, or distributor review. If a shipment or FDA deadline arrives sooner than the regulatory update limit, that commercial event becomes the real deadline.

Replacement playbook

1. Establish exactly what happened

Action: Obtain the resignation, termination notice, unpaid-renewal notice, or service correspondence. Confirm the effective date, whether the old agent has already notified FDA, and whether it still has access to the facility record.

Expected outcome: You can classify the problem as a commercial service lapse, a formal resignation not yet reflected in FDA records, or a completed FDA-system removal or rejection.

Gotchas: Do not assume that an expired invoice automatically removed the agent from FDA records. The opposite is equally risky: a portal may still display the old agent after the relationship has ended.

Time estimate: 15–30 minutes if the termination documentation is available.

2. Check the registration record and recover account control

Action: Log in through the owner/operator or authorized registrant account and inspect the current status, agent information, official correspondent, renewal date, and recent submissions. Use FURLS/FFRM for food, FURLS/DRLM for devices, the applicable drug registration and SPL workflow for drugs, and Cosmetics Direct for cosmetics.

Expected outcome: You know what FDA currently sees and which authorized account can submit the replacement.

Gotchas: A former provider may have acted as both U.S. Agent and official correspondent, particularly for medical devices. FDA allows those roles to be held by the same party, but they remain distinct; changing the agent does not necessarily recover the official-correspondent account. Device establishments can review and edit agent information in DRLM, while Cosmetics Direct displays registration status and renewal information. FDA DRLM update instructions and FDA Cosmetics Direct document those workflows.

Time estimate: 30–90 minutes with working credentials; longer if ownership or access must be recovered.

3. Put the importer and broker on notice

Action: If a shipment is booked, in transit, or expected within the next several days, tell the importer and customs broker that the U.S. Agent designation is being replaced. Give them one controlled set of facility names, addresses, registration identifiers, product details, and contact information.

Expected outcome: The entry is not filed using conflicting registration or agent information, and the commercial team knows whether shipment timing should be adjusted.

Gotchas: Do not present the agent issue as the confirmed cause of a hold unless the FDA or broker notice identifies a registration defect. Product coding, listing, labeling, Prior Notice, and importer data can produce separate entry problems.

Time estimate: Same day; immediately if the shipment is within 72 hours of arrival.

4. Appoint a replacement with authority to act

Action: Give the replacement agent the legal facility name, physical address, registration or owner/operator numbers, product vertical, current account contacts, prior agent details, resignation evidence, and any active shipment or FDA notice. The registrant must authorize the new designation; a prospective agent cannot simply appoint itself.

Expected outcome: The replacement has enough information to accept the role and prepare the correct update without rebuilding the file through repeated requests.

Gotchas: FDA permits only one designated U.S. Agent for each applicable foreign establishment record. The replacement must meet the physical U.S. presence requirements for the relevant vertical, and food and device workflows include agent-verification or acceptance mechanics.

Time estimate: As of August 2026, FDA Entry Point responds to inquiries within 24 business hours and submits a completed U.S. Agent registration update within one business day once the required information is available. Submission is not the same as FDA confirmation. FDA Entry Point food U.S. Agent process

5. Submit the change in the correct FDA system

Action: Complete the vertical-specific update rather than treating “FDA registration” as one shared database.

Vertical Replacement action Critical completion point
Food and beverage Update the U.S. Agent in the Food Facility Registration Module. A confirmed food facility generally has 60 calendar days to update the record after the agent stops serving. The new agent has agreed to serve and the registration update is confirmed. FDA may hold food shipments when a foreign facility has not registered in accordance with the U.S. Agent requirement. FDA food facility registration Q&A
Medical devices Update the U.S. Agent in FURLS/DRLM and report the change within 10 business days. The new agent completes the emailed confirmation process. An unconfirmed receipt code is automatically cancelled after 10 business days. FDA device U.S. Agent confirmation instructions
Drugs and pharmaceuticals The registrant designates the replacement through the applicable establishment-registration submission and updates agent information within 30 calendar days. The updated registration is accepted and remains aligned with the establishment’s drug listings and official contact. 21 CFR 207.69
Cosmetics Update the foreign facility’s U.S. Agent contact information through Cosmetics Direct or the applicable SPL submission route. The amended facility registration reflects the new contact. MoCRA requires changes to required registration content within 60 days rather than imposing a universal same-day cancellation rule. FDA Direct cosmetics user guide

Expected outcome: The new agent designation reaches the FDA system that governs the affected establishment.

Gotchas: “Submitted” may not mean “confirmed,” “accepted,” or “active.” Save the submission identifier and watch for a separate verification request, rejection, validation error, or confirmation message.

Time estimate: Often the same day to one business day for a complete submission; FDA confirmation and system processing can extend the timeline.

6. Confirm continuity rather than stopping at submission

Action: Obtain the accepted submission, agent-confirmation evidence where applicable, current registration status, and a screenshot or export of the updated record. Send the controlled information set to the importer, broker, regulatory team, and authorized account owner.

Expected outcome: Every party uses the same current agent and registration information for shipments, FDA communications, and future renewals.

Gotchas: Check whether the former provider remains an official correspondent, authorized submitter, additional contact, or account administrator. Removing one role may not remove the others.

Time estimate: 30–60 minutes after confirmation becomes available.

7. Audit what may have been missed during the gap

Action: Review FDA emails, portal messages, inspection correspondence, renewal notices, broker messages, and product-listing changes from the last confirmed date of active coverage. Ask the prior agent to transfer outstanding communications and submission history.

Expected outcome: The organization knows whether the incident was only an agent-continuity problem or whether a registration, listing, shipment, inspection, or enforcement matter also requires action.

Gotchas: Replacing the agent does not automatically release a detained shipment, correct an expired registration, update a product listing, or resolve a substantive product violation. Use the urgent FDA help playbook when a shipment is already held, refused, or connected to an import alert.

Time estimate: One to two hours for an initial audit; longer when the old provider controls historical records.

Will FDA notify you that the U.S. Agent is no longer valid?

FDA notification should be treated as a backstop, not an early-warning system. FDA does notify foreign food facilities after an agent records its withdrawal and requests a replacement, and the device system informs the establishment when an agent rejects, fails to confirm, or discontinues the association. Those messages occur after a system event and may be sent to an owner/operator or official-correspondent address that is itself stale. FDA food facility registration guidance and FDA device confirmation guidance describe these notifications.

Cosmetics Direct sends automated reminders before biennial facility-renewal dates, including to the U.S. Agent and other recorded contacts, but a renewal reminder is not advance notice that a private service contract is ending. Drug registration rules place the update obligation on the registrant and allow only the registrant to designate the replacement. FDA Cosmetics Direct and 21 CFR 207.29 establish those responsibilities.

What “locked out of the U.S. market” means in practice

There is no single cross-FDA switch that automatically cancels every foreign establishment the moment an agent contract ends. The practical risk is that a required registration record becomes outdated, unconfirmed, or unable to support import review while the manufacturer still believes it is covered.

  • Food: FDA may hold shipments at the port when a foreign facility has not registered in accordance with the U.S. Agent requirement, continuing the hold until the registration identifies an agent who has agreed to serve. FDA food facility registration Q&A
  • Medical devices: U.S. Agent information is part of the required updated registration, and no device may be imported unless it is listed and manufactured at a registered foreign establishment.
  • Drugs and medical devices: FDA Import Alert 99-34 provides for detention without physical examination of products from firms without valid registration or listing. An agent gap does not prove that every registration is already invalid, but it should be corrected before it contributes to an invalid or unreliable record. FDA Import Alert 99-34
  • Cosmetics: The foreign facility’s U.S. Agent is required registration information, and changes must be reported within 60 days. The statutory structure uses an update duty rather than automatic same-day cancellation solely because an agent resigns.

The operational rule is stricter than the longest legal deadline: restore the designation before the next shipment, FDA communication, inspection request, or renewal event.

FDA Entry Point is the best fit when…

  • The prior U.S. Agent has resigned, lapsed, or stopped responding and the manufacturer needs both a replacement designation and a review of the surrounding registration record.
  • A shipment is approaching and the team needs a U.S.-based liaison that can coordinate with the manufacturer, importer, broker, and applicable FDA registration system.
  • The manufacturer lacks a dedicated U.S. regulatory hire or needs one provider across food, cosmetics, medical devices, and drugs.
  • The previous service was mailbox-only and did not manage renewal tracking, product listings, SPL, GUDID/UDI, Prior Notice, or registration amendments.

FDA Entry Point files U.S. Agent designations, relays urgent communications, and tracks registration updates and renewal deadlines across the four covered verticals. FDA Entry Point’s process is therefore most relevant when the failure involves both agent continuity and the records surrounding it.

FDA Entry Point is not the whole fix when…

  • The underlying problem is product adulteration, a serious quality-system failure, unsupported claims, or another substantive violation.
  • The matter requires formal legal defense, a detention hearing, import-alert removal, litigation strategy, or contested statutory interpretation.
  • The shipment problem is unrelated to the agent or registration, such as incorrect product coding, missing Prior Notice, or a listing mismatch that requires separate correction.

If the current agent has not yet resigned

If the designation remains active and the issue is poor service, missed renewals, or a planned vendor change, use the switching FDA U.S. Agents playbook. A planned switch allows time to audit account access and adjacent filings; this playbook is for the narrower continuity problem created by resignation, lapse, removal, or an uncertain agent status.

Frequently asked questions

What happens to my FDA registration if my U.S. Agent resigns?

The resignation creates a required registration update, but the exact consequence depends on the product vertical and the FDA system. Food facilities generally have 60 calendar days to replace a departing agent, while device changes must be reported within 10 business days, drug agent changes within 30 calendar days, and cosmetic registration changes within 60 days. A portal may continue showing the former agent temporarily, but that does not make the relationship valid. FDA food U.S. Agent guidance and 21 CFR 807.40 illustrate the different clocks.

How quickly do I need to replace a U.S. Agent that dropped my account?

You should start the replacement immediately and complete it before the next shipment or FDA deadline, even when the formal update period is longer. The maximum update windows vary—10 business days for medical device agent changes, 30 calendar days for drug agent information, and 60 calendar days for food and cosmetic registration information—but those windows are not safe waiting periods when goods are already moving. FDA Entry Point responds to inquiries within 24 business hours and submits completed agent updates within one business day. FDA Entry Point medical device U.S. Agent process

Does FDA notify me if my U.S. Agent listing becomes invalid?

FDA may notify you after a food or medical device agent withdraws, rejects the designation, or fails to confirm, but you should not rely on that message as advance warning. The notification can arrive after the agent relationship has already ended and may go to an outdated owner/operator or official-correspondent address. Contract renewal monitoring, periodic portal checks, and current account contacts remain the manufacturer’s responsibility. FDA device agent notification instructions

Can I be locked out of the U.S. market if I have no active U.S. Agent?

Yes, market access can be interrupted, although an agent resignation does not create one universal same-day lockout across every FDA center. FDA may hold food shipments until a valid agent is added, and drugs or devices from firms without valid registration or listing can face detention without physical examination. Cosmetics follow a 60-day registration-update duty for changed required information. The safest operating standard is to restore the agent and confirm the updated record before the next import entry. FDA Import Alert 99-34

Will appointing a new U.S. Agent release a shipment that is already detained?

A new U.S. Agent will not release a detained shipment by itself unless the missing designation is the only defect and FDA accepts the corrected record. The notice may also identify an expired registration, missing product listing, Prior Notice error, labeling problem, import alert, or substantive product violation. Replace the agent quickly, but build the response around the actual Notice of FDA Action and its deadline rather than assuming the contact change resolves the entire entry.

References